Teladoc Health, Inc. (TDOC)
NYSE: TDOC · Real-Time Price · USD
6.81
-0.15 (-2.16%)
At close: Aug 14, 2026, 4:00 PM EDT
6.83
+0.02 (0.29%)
After-hours: Aug 14, 2026, 7:58 PM EDT

Teladoc Health Stock Forecast

Stock Price Forecast

According to 24 analysts polled by S&P Global, Teladoc Health stock has a consensus rating of "Hold" and an average price target of $7.79. The average 1-year stock price forecast is 14.39% higher than the current stock price, while the lowest is $5.50 (-19.24%) and the highest is $10.5 (+54.19%).

Price Target: $7.79 (+14.39%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price$5.50$7.79$7.50$10.5
Change-19.24%+14.39%+10.13%+54.19%

Analyst Ratings

The average analyst rating for Teladoc Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy666655
Buy111111
Hold191919181818
Sell000000
Strong Sell000000
Total262626252424

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Truist Financial
Truist Financial
Hold
Reiterates
$9$8
HoldReiterates$9$8+17.47%Aug 14, 2026
Oppenheimer
Oppenheimer
Buy
Reiterates
$7
BuyReiterates$7+2.79%Aug 4, 2026
TD Cowen
TD Cowen
Hold
Maintains
$6
HoldMaintains$6-11.89%Aug 4, 2026
Citi
Citi
Hold
Maintains
$11$7.5
HoldMaintains$11$7.5+10.13%Aug 3, 2026
Barclays
Barclays
Hold
Maintains
$7
HoldMaintains$7+2.79%Aug 3, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
2.42B
from 2.53B
Decreased by -4.17%
Revenue Next Year
2.40B
from 2.42B
Decreased by -0.89%
EPS This Year
-0.78
from -0.66
EPS Next Year
-0.79
from -0.78
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
2.03B2.41B2.60B2.57B2.53B2.42B
Revenue Growth
85.81%18.41%8.13%-1.26%-1.54%-4.17%
Gross Profit
1.38B1.66B1.84B1.82B1.76B1.66B
Gross Margin
68.01%69.09%70.80%70.76%69.50%68.56%
Operating Income
-238.99M-217.47M-210.50M-208.79M-163.40M-163.11M
Net Income
-428.79M-13.66B-220.37M-1.00B-200.32M-159.34M
EPS
-----0.66-0.78
Free Cash Flow
241.62M176.62M303.95M229.78M226.14M148.03M
No. Analysts
-----21
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High2.5B
Avg2.4B
Low2.4B

Revenue Growth

Revenue Growth202620272028
High
-0.5%
Avg
-4.2%
Low
-6.6%

EPS Forecast

EPS202620272028
High-0.65
Avg-0.78
Low-0.99

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-